It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Transcriptional regulator MtrR inhibits the expression of the multidrug efflux pump operon mtrCDE in the pathogenic bacterium Neisseria gonorrhoeae. Here, we show that MtrR binds the hormonal steroids progesterone, β-estradiol, and testosterone, which are present at urogenital infection sites, as well as ethinyl estrogen, a component of some hormonal contraceptives. Steroid binding leads to the decreased affinity of MtrR for cognate DNA, increased mtrCDE expression, and enhanced antimicrobial resistance. Furthermore, we solve crystal structures of MtrR bound to each steroid, thus revealing their binding mechanisms and the conformational changes that induce MtrR.
Transcriptional regulator MtrR inhibits the expression of the multidrug efflux pump operon mtrCDE in Neisseria gonorrhoeae. Here, Hooks et al. show that hormonal steroids bind to MtrR and decrease its affinity for cognate promoters, thus leading to increased mtrCDE expression and enhanced antimicrobial resistance.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Duke University School of Medicine, Department of Biochemistry, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
2 Emory University School of Medicine, Department of Microbiology and Immunology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); Centers for Disease Control and Prevention, STD Laboratory Reference and Research Branch, Division of STD Prevention, Atlanta, USA (GRID:grid.416738.f) (ISNI:0000 0001 2163 0069)
3 Emory University School of Medicine, Department of Microbiology and Immunology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)
4 Princeton University, Department of Molecular Biology, Princeton, USA (GRID:grid.16750.35) (ISNI:0000 0001 2097 5006)
5 Duke University Medical Center, Division of Infectious Diseases, Department of Medicine, Durham, USA (GRID:grid.189509.c) (ISNI:0000 0001 0024 1216)
6 Emory University School of Medicine, Department of Microbiology and Immunology, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502); Veterans Affairs Medical Center, Laboratories of Microbial Pathogenesis, VA Medical Research Service, Decatur, USA (GRID:grid.414026.5) (ISNI:0000 0004 0419 4084); Emory University School of Medicine, Emory Antibiotic Resistance Center, Atlanta, USA (GRID:grid.189967.8) (ISNI:0000 0001 0941 6502)